155 related articles for article (PubMed ID: 18231621)
21. The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
Murasawa H; Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Iwabuchi I; Ogasawara M; Kawaguchi T
Int J Clin Oncol; 2017 Feb; 22(1):159-165. PubMed ID: 27534866
[TBL] [Abstract][Full Text] [Related]
22. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
Izawa JI; Chin JL; Winquist E
Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
[TBL] [Abstract][Full Text] [Related]
23. T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.
De Berardinis E; Busetto GM; Antonini G; Giovannone R; Gentile V
Int Urol Nephrol; 2011 Dec; 43(4):1047-57. PubMed ID: 21442469
[TBL] [Abstract][Full Text] [Related]
24. Novel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients.
Patel S; Dinh T; Noah-Vanhoucke J; Rengarajan B; Mayo K; Clark PE; Kamat AM; Lee CT; Sexton WJ; Steinberg GD
Bladder Cancer; 2015 Oct; 1(2):143-150. PubMed ID: 27376114
[No Abstract] [Full Text] [Related]
25. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer.
Hayter CR; Paszat LF; Groome PA; Schulze K; Math M; Mackillop WJ
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1239-45. PubMed ID: 10613319
[TBL] [Abstract][Full Text] [Related]
26. Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer.
Pang KH; Noon AP
Transl Androl Urol; 2019 Feb; 8(1):101-107. PubMed ID: 30976574
[TBL] [Abstract][Full Text] [Related]
27. High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.
Koch GE; Luckenbaugh AN; Chang SS
Urology; 2021 Jan; 147():7-13. PubMed ID: 32445767
[TBL] [Abstract][Full Text] [Related]
28. A preoperative scoring system to predict the probability of laparoendoscopic single-site extracorporeal cystectomy in patients with benign ovarian cysts.
Tan W; Deng Y; Deng L; Tang S; Yao Y; Wei H; Zhong K; Wang Y
Front Surg; 2022; 9():991450. PubMed ID: 36386511
[TBL] [Abstract][Full Text] [Related]
29. Radical cystectomy: do we need standardization?
Ladurner C; Comploj E; Trenti E; Palermo S; Pycha A; Pycha A
Expert Rev Anticancer Ther; 2017 Feb; 17(2):101-107. PubMed ID: 27937057
[TBL] [Abstract][Full Text] [Related]
30. Orthotopic neobladder reconstruction after radical cystectomy in patients with a solitary functioning kidney: clinical outcome and evaluation.
Helmy Aly A; Ezzat A; Hamed A
J Egypt Natl Canc Inst; 2011 Dec; 23(4):133-40. PubMed ID: 22776840
[TBL] [Abstract][Full Text] [Related]
31. Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate.
Lavery HJ; Stensland KD; Niegisch G; Albers P; Droller MJ
J Urol; 2014 Apr; 191(4):898-906. PubMed ID: 24300483
[TBL] [Abstract][Full Text] [Related]
32. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder.
Dinney CP; Babkowski RC; Antelo M; Perrotte P; Liebert M; Zhang HZ; Palmer J; Veltri RW; Katz RL; Grossman HB
J Urol; 1998 Oct; 160(4):1285-90. PubMed ID: 9751337
[TBL] [Abstract][Full Text] [Related]
33. Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.
Sato Y; Kondo T; Takagi T; Junpei I; Tanabe K
Int Urol Nephrol; 2016 Apr; 48(4):503-9. PubMed ID: 26759324
[TBL] [Abstract][Full Text] [Related]
34. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
Brauers A; Buettner R; Jakse G
J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
[TBL] [Abstract][Full Text] [Related]
35. Editorial Comment from Dr Ide to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
Ide H
Int J Urol; 2022 Sep; 29(9):937-938. PubMed ID: 35218081
[No Abstract] [Full Text] [Related]
36. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
37. [Clinical study of carcinoma in situ of the urinary bladder].
Harada Y; Seguchi T; Nonomura N; Kojima Y; Miki T; Okuyama A
Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):693-7. PubMed ID: 9780653
[TBL] [Abstract][Full Text] [Related]
38. [Immediate effects and general conditions of a total cystectomy for cancer; 11 cases].
CHAUVIN HF
Mars Chir; 1955; 7(3):296-9. PubMed ID: 13243905
[No Abstract] [Full Text] [Related]
39. Editorial Comment from Dr Taoka and Dr Sugimoto to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
Taoka R; Sugimoto M
Int J Urol; 2022 Sep; 29(9):936-937. PubMed ID: 35170098
[No Abstract] [Full Text] [Related]
40. Analysis of the efficacy of a single subumbilical stoma for bilateral cutaneous ureterostomy after radical cystectomy.
Fu Z; Tian Z; Chen Y; Jia Z; Wang C; Zhang X; Zhang W; Li G; Wei X; Huang Y
Eur J Med Res; 2023 Aug; 28(1):273. PubMed ID: 37550747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
